HF
HURA

HRT Financial’s TuHURA Biosciences HURA Stock Holding History

HRT Financial’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
+20,235
New +$47.1K ﹤0.01% 3789
2024
Q2 		– Sell
-2,332
Closed -$8K – 3277
2024
Q1 		$8K Buy
+2,332
New +$9.37K ﹤0.01% 2088
2022
Q4 		– Sell
-22
Closed -$4K – 3299
2022
Q3 		$4K Buy
+22
New +$7.03K ﹤0.01% 2613

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial's HURA Position: Q2 2026 in Review

HRT Financial opened a new position in TuHURA Biosciences (HURA) in Q2 2026: 20,235 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #3789 among its holdings. This is a return to the name: HRT Financial previously reported a position in HURA as recently as Q1 2024.

HRT Financial first reported a position in HURA in Q3 2022 and has held it in 3 quarters since. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • HRT Financial held 20,235 shares of TuHURA Biosciences worth $47K as of Q2 2026.
  • TuHURA Biosciences was a new HRT Financial position in Q2 2026.
  • TuHURA Biosciences made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3789 holding.
  • HRT Financial first reported a position in TuHURA Biosciences in Q3 2022 and has held it in 3 quarters since.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.